USPTO serial 79032406
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
E-37004 Salamanca, ES
Other trademarks owned by CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
E-37004 Salamanca, ES
Other trademarks owned by CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
E-37004 Salamanca, ES
Other trademarks owned by CENTRO DE INVESTIGACION BIOMOLECULAR APLICADA SALAMANCA, S.L.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd A. Denys
TODD A. DENYS MATTHEWS SHEPHERD MCKAY & BRUNEAU PA29 THANET ROAD SUITE 201PRINCETON, NJ 08540-3674UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-cancer preparations; pharmaceutical products and vaccines for the treatment of viral and infectious diseases, for the prevention and treatment of cancer; radiopharmaceutical imaging and detection agents for diagnosis and monitoring cancer; radioactive substances for use in nuclear medicine; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals | SECTION 71 - CANCELLED | — |
| 042 | MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS AND IN THE FIELD OF MEDICAL IMAGING; DEVELOPMENT OF PHARMACEUTICAL PREPARATIONS AND MEDICINES IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS; ANALYSIS OF THE MODE OF ACTION OF CHEMICAL COMBINATIONS ON ANIMALS; BIOLOGICAL CLONING SERVICES; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES, PHARMACEUTICAL RESEARCH AND DEVELOPMENT; RESEARCH AND DEVELOPMENT OF VACCINES AND MEDICINES; RESEARCH, DEVELOPMENT AND CONSULTATION RELATED THERETO IN THE FIELD OF CANCER PREVENTION, TREATMENT AND DIAGNOSIS; SCIENTIFIC INVESTIGATIONS FOR MEDICAL PURPOSES; SCIENTIFIC RESEARCH IN THE FIELD OF GENETICS AND GENETIC ENGINEERING | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2017 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| May 19, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 19, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 24, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 30, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 30, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 20, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 20, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jun 5, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 19, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 19, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 13, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 13, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 28, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 24, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 24, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 29, 2007 | PAPER RECEIVED | — | |
| Mar 29, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 8, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 7, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 28, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |